AMR funding increase in president’s FY 2027 budget is promising but only if other deep cuts in the proposed budget are rejected

The proposed $22 million increase for the Centers for Disease Control and Prevention's Antibiotic Resistance Solutions Initiative in the president's FY 2027 budget request is a critical step toward expanding our nation's capacity to prevent, detect and respond to drug-resistant infections.

However, the deep cuts to biomedical research and public health proposed in the president's budget request, including an approximate 30% proposed cut to CDC overall, a 12% cut in overall NIH funding and a $1.8 billion reduction in funding for the National Institute of Allergy and Infectious Diseases, will greatly limit the effectiveness of the targeted investment in AMR and other vital ID activities.

IDSA urges Congress to approve the $22 million increase in the AR Solutions Initiative (or ideally provide a deeper investment in the program) and reject these damaging proposed cuts to other vital public health and biomedical research programs. We will continue to advocate for robust investments for the full breadth of domestic and global ID programs. Read HIVMA's statement on the proposed cuts to HIV funding.

ID programs within the Department of Health and Human Services in the president's FY 2027 budget:

National Institutes of Health

• Funds NIAID at $4.751 billion, a $1.8 billion cut below the FY 2026 level of $6.546 billion
• Maintains NIAID as one institute
• Eliminates the Fogarty International Center
• Caps indirect cost rates at 15%, claiming that only necessary project costs (not administrative overhead) will be funded
• Proposes to fully fund upfront all research project grants in 2027

Centers for Disease Control and Prevention

• $219 million for the AR Solutions Initiative, a $22 million increase over FY 2026 funding
• $66 million for the Advanced Molecular Detection program, an increase of $23 million over FY 2026
• $24 million for the National Healthcare Safety Network program, level with FY 2026
• $663 million for the Center for Global Health, a cut of $29 million compared to FY 2026; the proposal includes $293 million for Global Public Health Protection
• $128 million for the Global HIV/AIDS, and $11.7 million for Global Tuberculosis, programs, level with FY 2026
• Proposes realigning CDC's Viral Hepatitis, Sexually Transmitted Infections, Domestic TB, and Infectious Diseases and the Opioid Epidemic programs into a newly proposed line, Consolidated Hepatitis, STD and Tuberculosis Prevention Grant, under the new Administration for a Healthy America

State Department global health programs (compared to previous U.S. Agency for International Development and State Department combined figure): Funded at $5.123 billion, representing a 46% cut. The president's budget does not include any funding numbers for disease-specific global health programs that fall under the State Department. Rather, in an unusual move, the proposal eliminates "disease-specific accounts and provides the department crucial agility to address the actual needs of each recipient country - across HIV/AIDS and other infectious diseases such as malaria, tuberculosis and polio - to strengthen global health security and protect Americans from disease." The proposal does specify elimination of funding for family planning and reproductive health, along with funding for the Pan American Health Organization, the United Nations Population Fund and the World Health Organization.

About IDSA and HIVMA
The Infectious Diseases Society of America is a global community of 13,000 clinicians, scientists and public health experts working together to solve humanity's smallest and greatest challenges, from tiny microbes to global outbreaks. Rooted in science, committed to health equity and driven by curiosity, our compassionate and knowledgeable members safeguard the health of individuals, our communities and the world by advancing the treatment and prevention of infectious diseases. Within IDSA, the HIV Medicine Association is a community of health care professionals who advance a comprehensive and humane response to the HIV pandemic, informed by science and social justice. Visit idsociety.org and hivma.org to learn more.